Visual demonstration of weight loss and health risk improvement with a dual GIP and GLP-1 receptor agonist.

ABSTRACT:

Background

Body weight and health-outcome results of highly effective new GLP-1R agonist medicine trials are usually presented in scientific reports in the form of standard graphs and tables. These representations are not easily translated to what the average participant looked like or their health risks at the outset of the study and how improvements in adiposity and clinical measures changed with treatment. Two recently developed methods for visually presenting complex weight and health-risk information that encapsulate substantial amounts of clinical trial observations were recently developed that can potentially supplement and give new insights into conventional GLP-1R agonist scientific reports. The current study aim was to put these visual presentations into a demonstration f

SUBMITTER: Ramirez S 

PROVIDER: S-EPMC12532576 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature